{"protocolSection":{"identificationModule":{"nctId":"NCT00298597","orgStudyIdInfo":{"id":"GCSFEPO_01"},"secondaryIdInfos":[{"id":"EudraCT Number 2005-001113-18"}],"organization":{"fullName":"University Hospital Muenster","class":"OTHER"},"briefTitle":"Influence of G-CSF and EPO on Associative Learning and Motor Skills","officialTitle":"Influence of G-CSF and EPO on Associative Learning and Motor Skills"},"statusModule":{"statusVerifiedDate":"2007-04","overallStatus":"COMPLETED","expandedAccessInfo":{"hasExpandedAccess":false},"startDateStruct":{"date":"2006-03"},"primaryCompletionDateStruct":{"date":"2009-03","type":"ACTUAL"},"completionDateStruct":{"date":"2009-03","type":"ACTUAL"},"studyFirstSubmitDate":"2006-03-01","studyFirstSubmitQcDate":"2006-03-01","studyFirstPostDateStruct":{"date":"2006-03-02","type":"ESTIMATED"},"lastUpdateSubmitDate":"2009-04-22","lastUpdatePostDateStruct":{"date":"2009-04-23","type":"ESTIMATED"}},"sponsorCollaboratorsModule":{"leadSponsor":{"name":"University Hospital Muenster","class":"OTHER"}},"descriptionModule":{"briefSummary":"In the study we want to prove whether the subcutaneous application of granulocyte-stimulating factor (G-CSF) and erythropoetin (EPO) influence associative learning and/or motor skills of patients, who suffer from chronic stroke or amyotrophic lateral sclerosis. The study hypothesis is that G-CSF and EPO improve associative learning and/or motor skills."},"conditionsModule":{"conditions":["Chronic Stroke","Amyotrophic Lateral Sclerosis"]},"designModule":{"studyType":"INTERVENTIONAL","phases":["PHASE2"],"designInfo":{"allocation":"RANDOMIZED","interventionModel":"PARALLEL","primaryPurpose":"TREATMENT","maskingInfo":{"masking":"DOUBLE"}},"enrollmentInfo":{"count":180,"type":"ESTIMATED"}},"armsInterventionsModule":{"interventions":[{"type":"DRUG","name":"granulocyte - colony stimulating factor (G-CSF)"},{"type":"DRUG","name":"erythropoetin (EPO)"}]},"outcomesModule":{"primaryOutcomes":[{"measure":"Learning success in a word learning model"},{"measure":"Response time in motor function tests"}],"secondaryOutcomes":[{"measure":"Response time in a word learning model"},{"measure":"Total time and number of keystrokes in motor function tests"}]},"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Diagnosis of chronic stroke or amyotrophic lateral sclerosis\n\nExclusion Criteria:\n\n* leucocytes \\> 10000/µl\n* hematocrit \\> 48%\n* thrombocytes \\< 150000/µl\n* severe rheumatoid arthritis\n* severe infection\n* severe liver or renal failure\n* severe arterial hypertension\n* recurrent thromboembolic events\n* severe coronary heart disease\n* myocardial infarction\n* malignant tumor\n* leukemia\n* peripheral arterial occlusion disease","healthyVolunteers":false,"sex":"ALL","minimumAge":"18 Years","stdAges":["ADULT","OLDER_ADULT"]},"contactsLocationsModule":{"overallOfficials":[{"name":"Wolf Rüdiger Schäbitz, MD","affiliation":"Department of Neurology, University Hospital of Muenster, Germany","role":"PRINCIPAL_INVESTIGATOR"}],"locations":[{"facility":"Department of neurology, University Hospital of Muenster","city":"Muenster","state":"Nordrhein-Westfalen","zip":"D-48149","country":"Germany","geoPoint":{"lat":51.96236,"lon":7.62571}}]},"referencesModule":{"references":[{"pmid":"15236398","type":"BACKGROUND","citation":"Knecht S, Breitenstein C, Bushuven S, Wailke S, Kamping S, Floel A, Zwitserlood P, Ringelstein EB. Levodopa: faster and better word learning in normal humans. Ann Neurol. 2004 Jul;56(1):20-6. doi: 10.1002/ana.20125."},{"pmid":"16258290","type":"BACKGROUND","citation":"Schneider A, Kuhn HG, Schabitz WR. A role for G-CSF (granulocyte-colony stimulating factor) in the central nervous system. Cell Cycle. 2005 Dec;4(12):1753-7. doi: 10.4161/cc.4.12.2213. Epub 2005 Dec 27."},{"pmid":"16007267","type":"BACKGROUND","citation":"Schneider A, Kruger C, Steigleder T, Weber D, Pitzer C, Laage R, Aronowski J, Maurer MH, Gassler N, Mier W, Hasselblatt M, Kollmar R, Schwab S, Sommer C, Bach A, Kuhn HG, Schabitz WR. The hematopoietic factor G-CSF is a neuronal ligand that counteracts programmed cell death and drives neurogenesis. J Clin Invest. 2005 Aug;115(8):2083-98. doi: 10.1172/JCI23559. Epub 2005 Jul 7."},{"pmid":"21625426","type":"DERIVED","citation":"Floel A, Warnecke T, Duning T, Lating Y, Uhlenbrock J, Schneider A, Vogt G, Laage R, Koch W, Knecht S, Schabitz WR. Granulocyte-colony stimulating factor (G-CSF) in stroke patients with concomitant vascular disease--a randomized controlled trial. PLoS One. 2011;6(5):e19767. doi: 10.1371/journal.pone.0019767. Epub 2011 May 23."},{"pmid":"21423758","type":"DERIVED","citation":"Duning T, Schiffbauer H, Warnecke T, Mohammadi S, Floel A, Kolpatzik K, Kugel H, Schneider A, Knecht S, Deppe M, Schabitz WR. G-CSF prevents the progression of structural disintegration of white matter tracts in amyotrophic lateral sclerosis: a pilot trial. PLoS One. 2011 Mar 14;6(3):e17770. doi: 10.1371/journal.pone.0017770."}]}},"derivedSection":{"miscInfoModule":{"versionHolder":"2024-02-14"},"conditionBrowseModule":{"meshes":[{"id":"D000016472","term":"Motor Neuron Disease"},{"id":"D000000690","term":"Amyotrophic Lateral Sclerosis"}],"ancestors":[{"id":"D000019636","term":"Neurodegenerative Diseases"},{"id":"D000009422","term":"Nervous System Diseases"},{"id":"D000009468","term":"Neuromuscular Diseases"},{"id":"D000013118","term":"Spinal Cord Diseases"},{"id":"D000002493","term":"Central Nervous System Diseases"},{"id":"D000057177","term":"TDP-43 Proteinopathies"},{"id":"D000057165","term":"Proteostasis Deficiencies"},{"id":"D000008659","term":"Metabolic Diseases"}],"browseLeaves":[{"id":"M21996","name":"Stroke","relevance":"LOW"},{"id":"M15105","name":"Sclerosis","relevance":"LOW"},{"id":"M18569","name":"Motor Neuron Disease","asFound":"Lateral Sclerosis","relevance":"HIGH"},{"id":"M3714","name":"Amyotrophic Lateral Sclerosis","asFound":"Amyotrophic Lateral Sclerosis","relevance":"HIGH"},{"id":"M21248","name":"Neurodegenerative Diseases","relevance":"LOW"},{"id":"M12101","name":"Neuromuscular Diseases","relevance":"LOW"},{"id":"M15605","name":"Spinal Cord Diseases","relevance":"LOW"},{"id":"M5432","name":"Central Nervous System Diseases","relevance":"LOW"},{"id":"M28449","name":"TDP-43 Proteinopathies","relevance":"LOW"},{"id":"M28437","name":"Proteostasis Deficiencies","relevance":"LOW"},{"id":"M11329","name":"Metabolic Diseases","relevance":"LOW"},{"id":"T349","name":"Amyotrophic Lateral Sclerosis","asFound":"Amyotrophic Lateral Sclerosis","relevance":"HIGH"},{"id":"T1303","name":"Chronic Graft Versus Host Disease","relevance":"LOW"},{"id":"T4699","name":"Primary Lateral Sclerosis","relevance":"LOW"}],"browseBranches":[{"abbrev":"BC10","name":"Nervous System Diseases"},{"abbrev":"BC14","name":"Heart and Blood Diseases"},{"abbrev":"All","name":"All Conditions"},{"abbrev":"BC23","name":"Symptoms and General Pathology"},{"abbrev":"BC18","name":"Nutritional and Metabolic Diseases"},{"abbrev":"Rare","name":"Rare Diseases"}]},"interventionBrowseModule":{"meshes":[{"id":"D000068817","term":"Epoetin Alfa"}],"ancestors":[{"id":"D000006397","term":"Hematinics"}],"browseLeaves":[{"id":"M314","name":"Epoetin Alfa","asFound":"Moved to","relevance":"HIGH"},{"id":"M9175","name":"Hematinics","relevance":"LOW"}],"browseBranches":[{"abbrev":"Hemat","name":"Hematinics"},{"abbrev":"All","name":"All Drugs and Chemicals"}]}},"hasResults":false}